American Oriental Bioengineering first-quarter revenue increases 16.

– – Revenue from pharmaceutical products increased 17.8 percent to $40.9 million from $34.7 million in the first quarter of 2009, powered by improved demand for the Shuanghuanglian Injection Powder, CCXA and BOKE pharmaceutical products, along with the newly-launched products such as for example YuYeQingHuo Capsules. Revenue from prescription pharmaceutical products increased 29.3 percent to $20.9 million from $16.2 million in the last year period, reflecting a complete year over year upsurge in sales from the prescription Jinji capsule, SHL powder, CCXA and Boke prescription products.We might have identified different ways to use hypochlorite to essentially help patients. It may be easy, inexpensive and safe. .

Bioengineering heart parts Some day, heart attack survivors may have a patch of laboratory-grown muscle put into their heart, to displace areas that died throughout their attack. Children born with defective heart valves could easily get new ones that may grow in place, than being changed every couple of years rather. And folks with clogged or fragile arteries might get a fresh ‘natural’ replacement, of a factory-produced one instead. These possibilities are within reach, and could transform just how heart treatment is delivered, state University of Michigan Medical College researchers in the brand new problem of the journal Regenerative Medication.